Disruption in homeostasis of interleukin-15 (IL-15) is linked to poor maternal and fetal outcomes 32 during pregnancy. The only cells described to respond to IL-15 at the early maternal-fetal interface 33 have been natural killer (NK) cells. We now show a novel population of macrophages, evident in 34 several organs but enriched in the uterus of mice and humans, expressing the  chain of the IL-15 35 receptor complex (CD122) and responding to IL-15. CD122+ macrophages (CD122+Macs) are 36 morphologic, phenotypic, and transcriptomic macrophages that can derive from bone marrow 37 monocytes. CD122+Macs develop in the uterus and placenta with kinetics that mirror interferon 38 (IFN) activity at the maternal-fetal interface. Macrophage colony-stimulating factor (M-CSF) 39 permits macrophages to express CD122, and IFNs are sufficient to drive expression of CD122 on 40 macrophages. Neither Type-I nor Type-II IFNs are required to generate CD122+Macs, however. 41
at the maternal-fetal interface, IL-15 is bound to the cell surface of CD14+ monocytes and 80 macrophages in single cell suspensions of human first-trimester uterine decidua (9), the uterine 81 lining remodeled to accept an embryo. Consistent with these human data, pregnant mice lacking 82 c but reconstituted with bone marrow from Il15-/-mice exhibit normal uterine vascular 83 remodeling. These findings support that the dominant sources of IL-15 in mice also are non-84 hematopoietic cells and chemo-resistant myeloid cells (11). 85 86 Altogether, these data show that appropriate signaling by IL-15 is critically important to healthy 87 pregnancy. However, the targets and mechanisms of IL-15 signaling at the maternal-fetal interface 88 are incompletely understood. NK cells are the prototypical IL-15-responsive cell type at the 89 maternal-fetal interface. They are highly prevalent in the uterus and produce proinflammatory 90 interferon , without which uterine arteries do not remodel and preeclampsia develops in mice 91 (12). Because uterine and other NK cells clearly depend on IL-15 for development (3, 13) , it has 92 been presumed that NK cells are responsible for all abnormalities of pregnancy associated with 93 disrupted homeostasis of IL-15. 94 6 95
We now report that novel macrophages, termed CD122+Macs, express high levels of CD122 in 96 the uterus of mice and humans. Macrophage colony-stimulating factor (M-CSF) permits Type-I 97 and -II interferons to drive expression of CD122 on these macrophages. CD122+Macs respond to 98 IL-15 by activating the ERK signaling cascade, and CD122+Macs stimulated with the Toll-like 99 receptor agonist CpG enhance production of pro-inflammatory cytokines in response to CD122+Macs represent a new and unexpected target of IL-15 in the utero-placental unit and, thus, 101 may have significant clinical implications in healthy and complicated pregnancies. 102
METHODS

104
Preparation of single-cell suspensions. Organs of interest were grossly dissected, weighed, 105 minced finely with scissors, and digested in medium containing Liberase TM (Roche) at a final 106 concentration of 0.28WU/mL and DNase (Roche) at a final concentration 30g/mL for 30 min at 107 37°C with intermittent agitation. Cells were passed through a 70m filter, and red blood cells 108
were lysed with ACK lysis buffer. Cells were again filtered and counted with a Countess 109 hemocytometer (Thermo Fisher Scientific) prior to proceeding to antibody staining for flow 110 cytometry or cell sorting. were exported as FCS files and analyzed using FlowJo 10 software. All antibody staining was 116 performed at 4°C in the dark. Prior to fluorescent antibody staining, cells were incubated with 117 mouse Fc block (TruStain FcX, Biolegend) or human Fc block (BD). Fixable, fluorescent 118 LIVE/DEAD viability dye (Thermo Fisher) was used in Blue, Aqua, Green, and Near-IR per 119 manufacturer recommendations. All antibodies, clones, and concentrations used for flow 120 cytometry and cell sorting are listed in Supplmental Table 3 Written informed consent was obtained from all subjects. All women were between the ages of 176 18 and 43, with no significant medical history and regular menstrual cycles (between 25-35 days 177 over the past 3 months). Endometrial biopsies were obtained from known fertile women 8 days 178
after an LH surge (secretory phase), which was detected in the urine by the Clearblue Ovulation 179
Test. All biopsies were obtained using a Pipelle Endometrial Suction Curette (Cooper Surgical). 180
All biopsies were dissociated and analyzed within 24 hours of collection. Single cell suspensions 181 were obtained as above. Laboratory. All animals used were between 6-12 weeks of age. While it was only possible to use 204 female mice to investigate uterine immune cells, both male and female mice were used for in vitro 205 experiments, yielding similar results. For pregnant female mice, presence of copulation plugs were 206 checked early each morning. Copulation was assumed to take place during the 12-hour dark cycle 207 (from 6PM-6AM in our facility). Thus, E0.5 denotes the morning that a copulation plug was first 208 detected. 209
210
RESULTS
211
CD122+ macrophages are enriched in the uterus in mice 212
To determine whether uterine leukocytes other than NK cells could be cellular targets of IL-15, 213
we comprehensively examined expression of CD122 on immune cells in pregnant female mice. 214
Populations of cells co-expressing CD122 and high levels of macrophage/monocyte-associated Fc 215  Receptor 1 (FcRI, CD64) and F4/80 were evident in several organs but were particularly 216 enriched in the uterus of pregnant and non-pregnant mice ( Fig. 1A, Supplemental Fig. 1A ). Other 217
myeloid-phenotype cells, such as Ly6G+ cells (neutrophils) and CD11cbrightMHCIIbright cells 218
(conventional dendritic cells, DCs), did not exhibit surface expression of CD122 ( Fig. 1A ). During 219 gestation, these CD122+ phenotypic macrophages (herein CD122+Macs) were present throughout 220 the maternal fetal interface: in the myometrium, mesometrial lymphoid aggregate of pregnancy 221 (MLAP), decidua, and placenta ( Fig. 1B) . Most CD122+Macs and cMacs were CD11cint, Ly6Clow/neg, CCR2hi, and MERTKhi, a constellation 232 of findings typically associated with macrophages ( Fig. 1C, 1D ). Aside from CD122, 233
CD122+Macs and cMacs could be distinguished by expression of MHC Class II (MHCII), with 234
CD122+Macs largely MHCIIlow and cMacs largely MHCIIhi (Fig. 1C) . We next tested whether CD122+Macs were most like macrophages or another cell type at the level 246 of the transcriptome. A monocyte-macrophage-specific reporter system, known as the MM-DTR 247 mouse, fluorescently labels with mCherry monocytes and macrophages that transcribe both Lyz2 248 (LysM) and Csf1r (macrophage colony-stimulating factor receptor, M-CSFR) (22). Expression of 249 CD122 directly correlated with expression of mCherry in F4/80bright cells in the uterus (Fig. 1E ). 250
We then sort-purified decidual CD122+Macs, cMacs, and NK cells to a purity of at least 95% 251 (Supplemental Fig. 1F ) and analyzed the transcriptome using microarrays. We found that 86.5% 252 of the variance in gene expression among these populations could be attributed to the first principal 253 component, PC1 ( Fig. 1F ). Clustering samples along PC1 clearly separated cMacs and 254
CD122+Macs from NK cells. Similarly, hierarchical clustering analysis showed that all 255 macrophages were closely related to each other but distantly related to NK cells ( Fig. 1G ). Among 256 genes enriched in CD122+Macs relative to NK cells were those classically associated with 257 macrophages, including numerous complement receptors, Toll-like receptors, and Cd68, Csf1r, 258 Fcgr1, Lyz2, and Cx3cr1 (Supplemental Table 1 ). Among genes enriched in NK cells relative to 259
CD122+Macs were those typically associated with innate and killer lymphocytes, including Ncr1 260 (NKp46), transcripts encoding cytolytic mediators, Ly49 receptors, and Eomes (Eomesodermin) 261
and Tbx21 (T-bet). Of note, some cytolytic genes, including Prf1 and several granzymes, were 262 modestly but significantly enriched in CD122+Macs relative to cMacs ( Fig. 1H , Supplemental  263   Table 2 ). Altogether, these data support the notion that CD122+Macs and cMacs are highly related 264 but distinct subtypes of uterine macrophages. 265
266
CD122+Macs are present in human endometrium and decidua 267
Given the unusual phenotype and restricted anatomic location of CD122+Macs in mice, we 268 assessed whether such macrophages were also found in the human uterus. We therefore examined 269 human secretory endometrium during the implantation window, as well as human first-trimester 270 decidua, for the presence of human CD122+Macs (hCD122+Macs). We relied on expression of 271 CD14 and CD64 to identify human classical monocytes and macrophages by flow cytometry 272 (Supplemental Fig. 3A ). We defined human NK (hNK) cells as CD14-CD56bright (uterine) or 273 CD14-CD56dim (blood). As expected, hNK cells were abundant in the uterus and expressed high 274 levels of CD122. 275
276
We then identified CD14/CD64+ cells enriched in the human pre-and post-implantation uterus 277 that expressed CD122 ( Fig Table  294 2). Overall, human CD122+Macs bore striking resemblance to murine CD122+Macs, supporting 295 the use of our murine model to obtain mechanistic insights into the biology of this novel uterine 296 macrophage in humans. 297 298
Mouse CD122+Macs can derive from monocytes 299
Our morphologic, phenotypic, and transcriptomic data supported that CD122+Macs were 300 macrophages. Myriad embryonic and adult progenitors give rise to macrophages in different 301 tissues (24, 25). Monocytes are recruited in large numbers to the gravid uterus during gestation 302 (26). We thus tested the hypothesis that CD122+Macs could derive from adult bone marrow 303 monocytes. Magnetic bead-purified Ly6Chi monocytes from adult mouse bone marrow of MM-304 DTR mice were adoptively transferred into pregnant recipients during the peri-implantation period 305 ( Fig. 3A and 3B ). Recipients were then sacrificed at mid-gestation. We observed tissue-specific 306 differences in phenotype of recovered donor cells with respect to both F4/80 and CD122. Donor 307 cells recovered from recipient blood, spleen, and bone marrow were almost uniformly F4/80int 308 ( Fig. 3B ), suggesting maintenance of monocyte fate. In contrast, donor cells recovered from 309 recipient peritoneum, myometrium, and decidua contained F4/80bright cells, suggesting some 310 conversion to tissue macrophages in these organs. 311
312
Despite conversion of monocytes to F4/80bright cells in the peritoneum, we found that transferred 313 monocytes converted to macrophages expressing high levels of CD122 only in the uterus (Fig.  314 3B). These data are consistent with our findings that CD122+Macs are enriched in the uterus in 315 the steady state. Of note, we performed this experiment with both pregnant and non-pregnant 316 donors with identical results (data not shown), suggesting no intrinsic differences in potential of 317 bone marrow monocytes between pregnant and non-pregnant mice. Altogether, our data support 318 a model in which bone marrow monocytes are recruited to the uterus and differentiate into 319
CD122+Macs. 320 321
Tissue-specific population dynamics of CD122+Macs during gestation 322
Populations of myeloid cells, including dendritic cells, monocytes, and macrophages, are in 323 constant flux at the maternal-fetal interface during gestation (26, 27). We thus investigated 324 population dynamics of uterine CD122+Macs before and during pregnancy in the mouse. The 325 myometrium exhibitied progressive percent enrichment of F4/80bright cells over the course of 326 gestation ( Fig. 4A and 4B ), which agrees with and extends prior findings (26). This was in contrast 327 to progressive declines in NK cells after mid-gestation ( Fig. 4A-C) , consistent with prior reports 328 (28). On a percentage basis, myometrial CD122+Macs were more apparent over the course of 329 gestation until E16.5 ( Fig. 4A and B ). By E12.5 and before E16.5, myometrial CD122+Macs also 330 exhibited more robust expression of CD122 on a per-cell basis. The absolute numbers of 331
CD122+Macs per gram of myometrial tissue remained relatively stable through mid-gestation but 332 declined thereafter (Fig. 4C) . 333
334
Similar to the myometrium, the combined decidual and placental layers exhibited progressive 335 decline in NK cells but progressive relative enrichment of CD122+Macs during pregnancy ( Fig.  336 4A and 4B). Unlike the myometrium, however, this relative enrichment of CD122+Macs in the 337 decidua and placenta appeared to be at the expense of F4/80bright cMacs in those tissue layers. Also 338 unlike the myometrium, a robust proportion and absolute number of CD122+Macs persisted as 339 gestation approached term ( Fig. 4B and 4C ). In the early post-implantation period through E10.5, 340
CD122+Macs expressed moderate amounts of CD122 in the decidua and placenta ( Fig. 4A and 341 4B). From E11.5 through E18.5, the last timepoint we examined before delivery, deciduo-342 placental CD122+Macs exhibited progressively more robust expression of CD122 on a per-cell 343
basis. 344 345
In the non-pregnant uterus, we observed a population of CD122+F4/80int cells that became less 346 apparent but persisted throughout pregnancy ( Fig. 4A and 4B) . These cells could have represented 347 monocytes/macrophages or F4/80+ uterine eosinophils (29). Our data confirmed that presumptive 348 eosinophils, with high side scatter properties and low to no expression of CD64, are abundant 349 within the bulk F4/80int population (data not shown). However, these cells were uniformly 350 negative for CD122. F4/80intCD122+ cells, on the other hand, exhibited lower side scatter 351
properties and were CD64+, consistent with monocytes/macrophages. These data reinforce a I IFN and IFN-stimulated genes (ISGs) (31), and Type-II IFN is apparent during the estrous phase 364 (32). In the pregnant myometrium, total IFN activity is low until E10, peaks between E11 and 365 E15, then returns to low levels after E15 (30). IFN activity is already robust in the developing 366 placenta at E10 but spikes dramatically after E10 through to term. showed strong enrichment of genes associated with interferon signaling and antiviral responses 373 ( Fig. 5A , Supplemental Table 2 ). With this information, we next sought to determine whether 374
IFNs were sufficient to drive expression of CD122 on decidual macrophages. F4/80+ cells in bulk 375 single-cell suspensions of early gestation decidual capsules exhibited a dose-dependent 376 upregulation of surface CD122 upon exposure to recombinant IFN, though this effect was 377 strongest in F4/80int cells ( Fig. 5B and data not shown). To extend these findings, we cultured 378 sort-purified uterine F4/80int monocytes in macrophage colony-stimulating factor (M-CSF) with 379 or without Type-I IFN. Consistent with the notion that culture in macrophage colony-stimulating 380 factor (M-CSF) results in endogenous production of Type-I IFN by macrophages (33), we did 381 observe some expression of CD122 on uterine monocytes cultured in M-CSF alone ( Fig. 5B and 382 5C). However, addition of IFN resulted in robust upregulation of CD122+ compared to culture 383 in M-CSF alone. 384 385 Further, we could derive CD122+Macs in vitro from nonadherent bone marrow cells. Traditional 386 bone marrow-derived macrophages cultured with M-CSF (BMDMs) upregulated CD122 in a dose-387 dependent fashion in response to both Type-I IFN and Type-II IFN ( Fig. 5D and 5E ). While 388 the ability to drive expression of CD122 on BMDMs was shared by both Type-I and II IFNs, we 389 did observe differential effects of Type-I and -II IFNs on expression of MHCII (Supplemental Fig.  390 4A), in agreement with prior reports (34). Consistent with endogenous production of Type-I IFN 391
by M-CSF-stimulated macrophages (33), blockade of the Type-I IFN receptor (IFNAR) nearly 392 abolished expression of CD122 by BMDMs cultured in M-CSF alone ( Fig. 5D and 5E ). Blockade 393 of the IFN receptor (IFNGR), however, had no effect on level of CD122 in BMDMs cultured in 394 M-CSF alone, suggesting that BMDMs do not produce endogenous IFN. Use of combined Type-395 I/Type-II IFN receptor knockout BMDMs (Ifnar-/-Ifngr-/-double-knockout, DKO) showed that 396 DKO BMDMs appropriately do not upregulate CD122 with IFN treatment (Fig. 5F ). However, 397
we detected modest but nonzero levels of CD122 on DKO BMDMs by virtue of culture in M-CSF. 398
Thus, IFNs enhance expression of CD122, but they are not strictly required for expression of 399 
Type-I and II interferons are not required for development of CD122+Macs in vivo 415
We next assessed whether responsivity to Type-I and/or II IFNs was required for development of 416 uterine CD122+Macs in vivo. As CD122+Macs could derive from monocytes, we chose to first 417 determine requirements for Type-I and II IFNs in generation of CD122+Macs with adoptive 418 transfer of BM monocytes. While recovery of adoptively transferred cells from mice not treated 419 with radiation or chemotherapy is low, this approach allows for testing of cell-intrinsic 420 requirements for Type-I and -II IFNs in development of uterine CD122+Macs in normal 421 pregnancy. As discussed above, both Type-I and -II IFNs are produced at the maternal-fetal 422 interface (30-32). Recently, Type-III IFN was shown to play a critical role in fetal protection 423 against infection with Zika virus in mice and humans (37, 38) . Thus, all three known families of 424 IFN are actively produced at the maternal-fetal interface. Combined with our data that either Type-425 I or -II IFN is sufficient to induce expression of CD122 on BMDMs in vitro, we hypothesized that 426 there would be no specific IFN required for development of CD122+Macs. In other words, any 427 class of IFN might be able to signal to uterine macrophages to differentiate into CD122+Macs. 428
Consistent with this hypothesis, donor-derived CD122+Macs were equally evident after transfer 429 of BM monocytes from wild-type, Type-I IFN receptor-deficient (IFNAR KO), Type-II IFN 430 receptor-deficient (IFNGR KO), and DKO mice ( Fig. 6A and 6B ). Consistent with these data, we 431 also found similar abundance of uterine CD122+Macs in non-pregnant IFNAR KO, IFNGR KO, 432 and DKO mice (Fig. 6C) . Altogether, these data support that receptivity to Type-I and -II IFNs, 433 alone or in combination, is not required for BM monocytes to reach the uterus and develop into 434
CD122+Macs. 435
436
IL-15 signals through CD122 to enhance function of CD122+Macs 437
Despite the observed expression of CD122 by CD122+Macs, if and how IL-15 signals to 438 macrophages remained unknown. IL-15 has been shown to signal through CD122 and the 439 common gamma chain (c), which results in phosphorylation of numerous downstream targets, 440
including ERK (39). To test for phosphorylation of ERK in CD122+Macs exposed to IL-15, we 441 first created CD122+BMDMs by culturing nonadherent bone marrow cells in M-CSF plus IFN. 442
Cytokines already present in culture, including exogenous IFN, were then removed by washing 443 adherent cells thoroughly and adding fresh, cytokine-free medium. Washed CD122+BMDMs 444 were then stimulated in the presence or absence of IL-15 pre-complexed to the  chain of the IL-445 15 receptor (IL-15R), which most closely approximates true presentation of IL-15 in vivo and 446 optimizes its activity (40) . BMDMs stimulated with IFN express IL-15R (41), which can 447 transduce IL-15 signals in the absence of CD122 in certain cell types (42). Use of a pre-associated 448 IL-15/IL-15R complex, rather than free IL-15, ensured that any effects seen by stimulating 449
CD122+BMDMs with IL-15 would be mediated through CD122/c and not IL-15R. After 30 450 minutes of stimulation, we observed robust phosphorylation of ERK1/2 in cells treated with the 451 IL-15 complex (Fig. 7A and 7B) . These data support that IL-15 signals through CD122 in 452 macrophages using the ERK/MAPK cascade, similar to other IL-15-responsive cell types. 453
454
We next tested whether IL-15 could act on CD122+Macs to modulate production of cytokines. 455
CD122+BMDMs stimulated with the Toll-like receptor 9 (TLR9) agonist CpG produced abundant 456 tumor necrosis factor  (TNF) and IL-6 ( Fig. 7C) . Those CD122+BMDMs co-stimulated with 457
CpG and IL-15 pre-complexed to IL-15R exhibited enhanced production of TNF and IL-6 ( Fig.  458 7C, Supplemental Fig. 7 ), but we did not observe changes in levels of IL-10 (data not shown). 459
Overall, these data support that CD122+Macs are novel cellular targets for IL-15. showing that inducible deletion of macrophages early in pregnancy causes complete fetal loss, 467 because macrophages sustain the vasculature of ovarian corpus luteum, required to produce 468 progesterone and maintain early pregnancy (29). 469
470
Macrophages are abundant at the maternal-fetal interface and have been shown to directly abut 471 blood vessels and NK cells (44). Fetal trophoblasts of the developing placenta are thought to 472 communicate bidirectionally with macrophages, but few studies have formally addressed this (45, 473 46). These findings suggest that uterine and placental macrophages serve numerous critical 474 functions in pregnancy but are likely heterogenous. Several groups have investigated macrophage 475 heterogeneity during pregnancy in mice and humans (47, 48), but subsets of uterine macrophages 476 remain incompletely described. In this work, we address a critical unmet need to gain a deeper 477 understanding of signals that drive phenotype and function of macrophages at the maternal-fetal 478 interface. 479
480
We found novel and unexpected uterine macrophages that express CD122 and respond to IL-15 481 under direction of M-CSF and IFNs. While IL-2 also signals to cells expressing CD122 and c, 482 IL-2 is absent from the maternal-fetal interface in the steady state (8). These data suggest that 483
CD122+Macs respond specifically to IL-15 during steady state pregnancy. Gene ontology analysis 484 confirmed that the transcriptome of CD122+Macs is enriched in ISGs. IFNs are classically 485 produced in response to viral infections, but IFNs are abundant in the cycling uterus and at the 486 maternal-fetal interface in the steady state. Type-I and -II IFNs were sufficient to drive expression 487 of CD122 on uterine and bone marrow-derived monocytes and macrophages. However, neither 488
Type-I nor Type-II IFN was required, alone or in combination, to generate CD122+Macs in the 489 uterus of knockout mice or from BM monocytes adoptively transferred into pregnant hosts. 490
Further, M-CSF alone could drive modest expression of CD122 on cultured BMDMs 491 independently of IFN. These data suggest that a combination of factors, likely including some we 492 have yet to investigate, promote development of CD122+Macs in the uterus. We also 493 acknowledge the possibility that Type-III IFN could play a role in shaping the fate of 494
CD122+Macs, though this remains to be tested. Type-III IFN is the most recently described IFN, 495 and extremely limited information is available about its presence at the maternal-fetal interface 496 (38) . Like Type-I and -II IFN, Type-III IFN signals through STAT1 and activates networks of 497 canonical ISGs (49, 50). Of note, Type-III IFN appears to activate a network of genes most similar 498 to that of Type-I IFNs (51). Future investigations are needed to address the effects of Type-III 499 IFN on uterine macrophages. Regulation of IFN during murine pregnancy has been thoroughly described (54). Levels 512 progressively rise to a peak at mid-gestation, after which levels halve but plateau to near-term. 513
The cells upon which we performed gene expression profiling were obtained on E7.5, when levels 514 of uterine IFN are known to be relatively low. Consistent with those data, gene expression and 515 gene ontology analyses of CD122+Macs appeared most consistent with a Type-I or -III IFN 516 signature. The transcriptome of CD122+Macs was dominated by ISGs, including Mx1, that are 517 induced preferentially in response to IFN-I and -III (49, 55). Further, CD122+Macs are largely 518
MHCIIlow in vivo. Type-II IFN has been shown to enhance expression of MHCII in antigen 519 presenting cells, while IFN-I has been shown to oppose IFN-II-mediated upregulation of MHCII 520 (34). We also showed that treatment of BMDMs with IFN in vitro led to upregulation of CD122 521 and MHCII, while treatment of BMDMs with IFN led to upregulation of CD122 but not MHCII. 522
The IFN system is complex and redundant, particularly the Type-I and Type-III families of IFNs, 523 each composed of several members. This makes isolating individual actors in vivo difficult. 524 Future work will be directed at dissecting this complex system to determine the in vivo IFN 525 requirements for generation of CD122+Macs during preganacy. 526
527
We observed that only macrophages, not other uterine myeloid cells, express CD122. Further, 528 only CD122+Macs, not CD122+ NK cells, experienced a boost in expression of CD122 on a per-529 cell basis that correlated with increased IFN activity during gestation. One interpretation is that 530 only macrophages are in close enough proximity to the local source of IFN to express CD122 531 under direction of IFNs. An alternative explanation is that upregulation of CD122 in response to 532 IFN is a mechanism unique to monocytes and macrophages. In support of this latter hypothesis, 533
we provided evidence in vitro that M-CSF-derived macrophages, not GM-CSF-derived 534 macrophages, responded to IFN by upregulating CD122. These data point to unique regulation of 535
Il2rb in macrophages, allowing it to be expressed rapidly upon signaling by IFNs. Relatively little 536 is known about transcriptional regulation of Il2rb (56, 57) , and further investigations into why 537 macrophages uniquely respond to IFN by upregulating CD122 are needed. This is especially true 538 in light of the fact that CD122+Macs express neither Eomes nor T-bet, which have been previously 539
shown to drive expression of Il2rb in killer lymphocytes (58). In summary, our data support the 540 notion that CD122 is a novel, macrophage-specific, IFN-stimulated gene. 541
542
Our data show that CD122+Macs can derive from BM monocytes, but the precise precursors of 543
CD122+Macs have yet to be determined. We found evidence of CD122+F4/80int cells in the non-544 pregnant uterus that likely represent CD122+ monocytes. These cells may represent an 545 intermediate through which CD122+Macs transit during gestation. It has long been appreciated 546 that M-CSF is critical for pregnancy and is positively regulated by sex hormones (43, 59, 60). M-547 CSF concentrations are at or below the limits of detection in the uterus of non-pregnant mice but 548 increase dramatically in the myometrium during gestation, reaching peak concentration at term 549 (26, 59, 60). Indeed, we showed that large, F4/80bright macrophages were absent from the non-550 pregnant uterus. The appearance of these cells in the pregnant uterus suggests they may derive 551 from uterine monocytes exposed to M-CSF. In contrast to the myometrium, concentration of M-552 CSF is modest and constant in the decidua and placenta as gestation progresses (59). Reinforcing 553 these data, additional work showed maintenance of myeloid cells in the growing myometrium and 554 decline of myeloid populations in the decidua as gestation progresses (26, 27). These data are 555 consistent with our observations that adoptively transferred monocytes converted into 556 F4/80brightCD122+Macs in the myometrium but not the decidua or placenta late in gestation (data 557 not shown). Altogether, these data are consistent with a model in which BM monocytes are 558 directed to develop into F4/80bright CD122+Macs by M-CSF and IFNs. 559 560 Finally, we found that CD122+Macs exhibit a biochemical and functional response to stimulation 561 with IL-15. Whether CD122+Macs respond to IL-15 in the same manner as classical IL-15-562 responsive killer lymphocytes, however, remains to be determined. It has long been appreciated 563 that IL-15 enhances cytotoxicity of NK cells (61), and we found it intruiging that CD122+Macs 564 expressed a number of cytolytic transcripts. IL-15 may be responsible for the expression of 565 granzymes and perforin observed in CD122+Macs, as IL-15 has been implicated in driving 566 expression of cytolytic mediators in human plasma cells (62), another non-traditional responder to 567 IL-15. 568
569
We also have yet to understand the specific stimuli responsible for activating uterine and placental 570 macrophages in vivo during pregnancy, but it is feasible that CD122+Macs respond to IL-15 by 571 enhancing production of proinflammatory cytokines that may favor or threaten a healthy 572 pregnancy. For instance, decidual CD122+Macs were enriched in Il18 transcript (encoding IL-573 18), which is known to support production of IFN at the maternal-fetal interface. Establishing 574 this link may have major clinical relevance. Mice deficient in IFN signaling fail to remodel 575 uterine spiral arteries into low-resistance, high-capacitance vessels (12). In the mouse, this has 576 been attributed to defective production of IFN by NK cells. Further, IL-12 and IL-18 appear to 577 play a key role in production of IFN at the maternal fetal interface, as mice deficient in either or 578 both of these cytokines exhibit similarly abnormal uterine artery remodeling as does the IFN KO 579 mouse (63). Thus, these mice develop the correlate of human preeclampsia (12, 64). At the same Lending validation to our findings in the mouse, we discovered that the human uterus contains a 587 population of CD122+Macs. We observed that these cells phenocopied mouse CD122+Macs, 588 with expression of CD122 and modest levels of NK cell markers, such as CD56, Perforin, and 589
Granzyme. Human CD122+Macs were not as abundant as mouse CD122+Macs early in gestation, 590 but we have yet to fully explore how this population changes over gestation in humans. We also 591 have yet to formally determine whether these human womb-associated, killer-like macrophages 592 develop, signal, and function like their murine counterparts. A prior report supports the notion 593 that IFNs may be able to drive expression of CD122 in human macrophages, as cultured human 594 blood monocytes can express CD122 after culture in high-dose IFN (66). Our findings greatly 595 extend and provide critical context for these prior data. How IFNs signal to human monocytes and 596 macrophages is a key area of ongoing investigation with clear implications for human pregnancy. 597
598
In summary, we have revealed that IFNs act on uterine macrophages to generate an entirely new 599 and unexpected IL-15-responsive cell type at the maternal-fetal interface, the CD122+ 600 macrophage. Given the importance of IL-15 in pregnancy, modulation of CD122+Macs may 601 represent a novel therapeutic target to support pregnancies threatened by fetal growth restriction, 602 fetal loss, and preeclampsia. 603 to PCA and HCA, control probes and low-variance probes in microarray data were filtered out. 852
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